SmithKline Beckman Corp said itopened an 8.5 mln dlr pharmaceutical manufacturing plant inTianjin, China.    The plant will make pharmaceutical products for the jointventure company, Tianjin Smith Kline and French Laboratories.    SmithKline said the joint venture combines Smith Kline andFrench Laboratories, the pharmaceutical unit of SmithKlineBeckman, the &lt;Tianjin Medical Co>, and &lt;Hebel Chemical Plant>in Tianjin.    The plant has the capability to produce one billion tabletsand 200 mln capsules a year. Reuter&#3;